Skip to main content
logo
Enorama Pharma AB (publ) (STO:ERMA)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.3300
0.00 (0.00%)
Jul 24, 2026, 11:50 AM CET

Enorama Pharma AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-1.01-6.7427.611.129.4412.95
Revenue Growth
--2363.16%-88.13%-27.06%152.77%
Gross Profit
-5.62-15.034.66-3.261.14.63
Operating Income
-57.01-62.81-47.52-42.13-41.47-26.94
Net Income
-65.27-75.14-43.81-44.61-42.03-27.74
Earnings Per Share
-0.91-1.01-0.72-1.09-4.49-3.61
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
17.763.042.096.154.1412.2
Total Debt
0000.441.913.79
Net Cash (Debt)
17.763.042.095.722.238.41
Net Cash Growth
282.14%45.66%-63.53%156.37%-73.49%-
Net Cash Per Share
0.240.040.040.210.281.36

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-46.09-59.26-35.7-41.35-32.96-30.16
Capital Expenditures
00000-0.06
Free Cash Flow
-46.09-59.26-35.7-41.35-32.96-30.22
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
555.79%223.02%16.87%-290.90%11.68%35.72%
Operating Margin
5638.87%932.18%-172.08%-3757.98%-439.16%-208.08%
Pretax Margin
6456.28%1115.15%-158.65%-3979.75%-445.09%-214.27%
Profit Margin
6456.28%1115.15%-158.65%-3979.75%-445.09%-214.27%
FCF Margin
4558.56%879.50%-129.30%-3688.58%-349.02%-233.44%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
11.28-21.147.3691.632.9210.67